Overview
TARP syndrome is an extremely rare, severe X-linked lethal multiple congenital anomaly syndrome. The acronym TARP stands for its four cardinal features: Talipes equinovarus (clubfoot), Atrial septal defect, Robin sequence (micrognathia, glossoptosis, and cleft palate), and Persistent left superior vena cava. The condition is caused by mutations in the RBM10 gene located on the X chromosome, which encodes an RNA-binding protein involved in alternative splicing regulation. TARP syndrome predominantly affects males and is typically lethal in utero or in the neonatal period. The syndrome affects multiple body systems. Cardiac abnormalities are a hallmark and may include atrial septal defects, ventricular septal defects, and other structural heart malformations, including the characteristic persistent left superior vena cava. Craniofacial features include Pierre Robin sequence with severe micrognathia (small jaw), cleft palate, and glossoptosis (posterior displacement of the tongue), which can cause significant airway obstruction. Skeletal abnormalities include bilateral talipes equinovarus (clubfoot). Additional features that have been reported include brain abnormalities such as cerebellar hypoplasia, syndactyly, polydactyly, and abnormalities of the auditory system. Affected males frequently present with hydrops fetalis or severe polyhydramnios prenatally. Due to the extremely high lethality of TARP syndrome in affected males, there is no established curative treatment. Management is supportive and palliative, focusing on airway management, cardiac stabilization, and comfort care. Carrier females are generally unaffected or may show very mild features. Genetic counseling is essential for families with a known RBM10 mutation. Prenatal diagnosis is possible through molecular genetic testing when the familial mutation has been identified. Fewer than 20 cases have been reported in the medical literature.
Also known as:
Clinical phenotype terms— hover any for plain English:
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
3 eventsCentre Cardiologique du Nord — NA
Centre Cardiologique du Nord
Centre Cardiologique du Nord
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for TARP syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for TARP syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for TARP syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to TARP syndrome.
Community
No community posts yet. Be the first to share your experience with TARP syndrome.
Start the conversation →Latest news about TARP syndrome
No recent news articles for TARP syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about TARP syndrome
What is TARP syndrome?
TARP syndrome is an extremely rare, severe X-linked lethal multiple congenital anomaly syndrome. The acronym TARP stands for its four cardinal features: Talipes equinovarus (clubfoot), Atrial septal defect, Robin sequence (micrognathia, glossoptosis, and cleft palate), and Persistent left superior vena cava. The condition is caused by mutations in the RBM10 gene located on the X chromosome, which encodes an RNA-binding protein involved in alternative splicing regulation. TARP syndrome predominantly affects males and is typically lethal in utero or in the neonatal period. The syndrome affects
How is TARP syndrome inherited?
TARP syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does TARP syndrome typically begin?
Typical onset of TARP syndrome is neonatal. Age of onset can vary across affected individuals.